View in EDS

Trastuzumab Deruxtecan for HER2-Low Metastatic Breast Cancer: Practical Considerations for Medical Oncologists and Pathologists in Australia.

Saved in:
Bibliographic Details
Title: Trastuzumab Deruxtecan for HER2-Low Metastatic Breast Cancer: Practical Considerations for Medical Oncologists and Pathologists in Australia.
Authors: Redfern A; Fiona Stanley Hospital, Murdoch, Western Australia, Australia.; University of Western Australia, Crawley, Western Australia, Australia.; Harry Perkins Institute of Medical Research, Nedlands, Western Australia, Australia., Lim E; St Vincent's Hospital, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia., Lakhani S; University of Queensland Centre For Clinical Research, Brisbane, Queensland, Australia.; Pathology Queensland, Brisbane, Queensland, Australia., Pathmanathan N; Westmead Breast Cancer Institute, Westmead Hospital, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.; Douglass Hanly Moir Pathology, Macquarie Park, Sydney, New South Wales, Australia., Selva-Nayagam S; Department of Medical Oncology, Royal Adelaide Hospital, Adelaide, South Australia, Australia., McCarthy N; ICON Cancer Centre Wesley, Auchenflower, Brisbane, Queensland, Australia.; University of Queensland, Brisbane, Queensland, Australia., Yeo B; Austin Health, Melbourne, Victoria, Australia.; Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia., Dessauvagie B; Clinipath Pathology, Osborne Park, Perth, Western Australia, Australia.; UWA Medical School, University of Western Australia, Crawley, Perth, Western Australia, Australia., Farshid G; Discipline of Medicine, University of Adelaide, Adelaide, South Australia, Australia.; Directorate of Anatomical Pathology, SA Pathology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Source: Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2026 Jun; Vol. 22 (3), pp. 381-391. Date of Electronic Publication: 2026 Jan 31.
Publication Type: Journal Article; Review
Journal Info: Publisher: Blackwell Pub. Asia Country of Publication: Australia NLM ID: 101241430 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1743-7563 (Electronic) Linking ISSN: 17437555 NLM ISO Abbreviation: Asia Pac J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41618680
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Trastuzumab Deruxtecan for HER2-Low Metastatic Breast Cancer: Practical Considerations for Medical Oncologists and Pathologists in Australia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Redfern+A%22">Redfern A</searchLink>; Fiona Stanley Hospital, Murdoch, Western Australia, Australia.; University of Western Australia, Crawley, Western Australia, Australia.; Harry Perkins Institute of Medical Research, Nedlands, Western Australia, Australia.<br /><searchLink fieldCode="AU" term="%22Lim+E%22">Lim E</searchLink>; St Vincent's Hospital, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Lakhani+S%22">Lakhani S</searchLink>; University of Queensland Centre For Clinical Research, Brisbane, Queensland, Australia.; Pathology Queensland, Brisbane, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Pathmanathan+N%22">Pathmanathan N</searchLink>; Westmead Breast Cancer Institute, Westmead Hospital, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.; Douglass Hanly Moir Pathology, Macquarie Park, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Selva-Nayagam+S%22">Selva-Nayagam S</searchLink>; Department of Medical Oncology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.<br /><searchLink fieldCode="AU" term="%22McCarthy+N%22">McCarthy N</searchLink>; ICON Cancer Centre Wesley, Auchenflower, Brisbane, Queensland, Australia.; University of Queensland, Brisbane, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Yeo+B%22">Yeo B</searchLink>; Austin Health, Melbourne, Victoria, Australia.; Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Dessauvagie+B%22">Dessauvagie B</searchLink>; Clinipath Pathology, Osborne Park, Perth, Western Australia, Australia.; UWA Medical School, University of Western Australia, Crawley, Perth, Western Australia, Australia.<br /><searchLink fieldCode="AU" term="%22Farshid+G%22">Farshid G</searchLink>; Discipline of Medicine, University of Adelaide, Adelaide, South Australia, Australia.; Directorate of Anatomical Pathology, SA Pathology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101241430%22">Asia-Pacific journal of clinical oncology</searchLink> [Asia Pac J Clin Oncol] 2026 Jun; Vol. 22 (3), pp. 381-391. <i>Date of Electronic Publication: </i>2026 Jan 31.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Blackwell+Pub%2E+Asia%22">Blackwell Pub. Asia </searchLink><i>Country of Publication: </i>Australia <i>NLM ID: </i>101241430 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1743-7563 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217437555%22">17437555 </searchLink><i>NLM ISO Abbreviation: </i>Asia Pac J Clin Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41618680
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/ajco.70069
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 381
    Titles:
      – TitleFull: Trastuzumab Deruxtecan for HER2-Low Metastatic Breast Cancer: Practical Considerations for Medical Oncologists and Pathologists in Australia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Redfern A
      – PersonEntity:
          Name:
            NameFull: Lim E
      – PersonEntity:
          Name:
            NameFull: Lakhani S
      – PersonEntity:
          Name:
            NameFull: Pathmanathan N
      – PersonEntity:
          Name:
            NameFull: Selva-Nayagam S
      – PersonEntity:
          Name:
            NameFull: McCarthy N
      – PersonEntity:
          Name:
            NameFull: Yeo B
      – PersonEntity:
          Name:
            NameFull: Dessauvagie B
      – PersonEntity:
          Name:
            NameFull: Farshid G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2026 Jun
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1743-7563
          Numbering:
            – Type: volume
              Value: 22
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Asia-Pacific journal of clinical oncology
              Type: main
ResultId 1